Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...

Net interest income was 14% higher YoY, at ₹587.7 crore, due to steady loan growth & higher interest margins than Q3 FY24 levels of ₹516 crore.